Pawinska-Wasikowska, K.; Wieczorek, A.; Balwierz, W.; Bukowska-Strakova, K.; Surman, M.; Skoczen, S.
Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia. Cancers 2022, 14, 458.
https://doi.org/10.3390/cancers14020458
AMA Style
Pawinska-Wasikowska K, Wieczorek A, Balwierz W, Bukowska-Strakova K, Surman M, Skoczen S.
Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia. Cancers. 2022; 14(2):458.
https://doi.org/10.3390/cancers14020458
Chicago/Turabian Style
Pawinska-Wasikowska, Katarzyna, Aleksandra Wieczorek, Walentyna Balwierz, Karolina Bukowska-Strakova, Marta Surman, and Szymon Skoczen.
2022. "Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia" Cancers 14, no. 2: 458.
https://doi.org/10.3390/cancers14020458
APA Style
Pawinska-Wasikowska, K., Wieczorek, A., Balwierz, W., Bukowska-Strakova, K., Surman, M., & Skoczen, S.
(2022). Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia. Cancers, 14(2), 458.
https://doi.org/10.3390/cancers14020458